BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11891194)

  • 1. Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation.
    Baatar D; Jones MK; Pai R; Kawanaka H; Szabo IL; Moon WS; Kitano S; Tarnawski AS
    Am J Pathol; 2002 Mar; 160(3):963-72. PubMed ID: 11891194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
    Berenguer B; Alarcón de la Lastra C; Moreno FJ; Martín MJ
    Eur J Pharmacol; 2002 May; 442(1-2):125-35. PubMed ID: 12020690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGF triggers activation of the COX-2 gene in rat gastric epithelial cells: action mediated through the ERK2 signaling pathway.
    Jones MK; Sasaki E; Halter F; Pai R; Nakamura T; Arakawa T; Kuroki T; Tarnawski AS
    FASEB J; 1999 Dec; 13(15):2186-94. PubMed ID: 10593866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB.
    Ahluwalia A; Baatar D; Jones MK; Tarnawski AS
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G602-10. PubMed ID: 25059824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
    Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
    J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
    Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS
    Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2.
    Brzozowski T; Konturek PC; Konturek SJ; Schuppan D; Drozdowicz D; Kwiecień S; Majka J; Nakamura T; Hahn E
    Digestion; 2001; 64(1):15-29. PubMed ID: 11549833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam.
    Berenguer B; Alarcón De La Lastra C; Motilva V; La Casa C; Herrerias JM; Pozo D; Calero MJ
    Dig Dis Sci; 2004 Jun; 49(6):937-47. PubMed ID: 15309881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
    Shishodia S; Aggarwal BB
    Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
    Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of cyclooxygenase-2 on formation and healing of acetic acid-induced gastric ulcer in rats].
    Shen X
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1380-3. PubMed ID: 11930633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal ulceration activates keratinocyte growth factor and its receptor in rats: implications for ulcer healing.
    Baatar D; Kawanaka H; Szabo IL; Pai R; Jones MK; Kitano S; Tarnawski AS
    Gastroenterology; 2002 Feb; 122(2):458-68. PubMed ID: 11832460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
    Tuynman JB; Buskens CJ; Kemper K; ten Kate FJ; Offerhaus GJ; Richel DJ; van Lanschot JJ
    Ann Surg; 2005 Dec; 242(6):840-9, discussion 849-50. PubMed ID: 16327494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
    Wallace JL; McKnight W; Reuter BK; Vergnolle N
    Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
    Yang HM; Kim HS; Park KW; You HJ; Jeon SI; Youn SW; Kim SH; Oh BH; Lee MM; Park YB; Walsh K
    Circulation; 2004 Jul; 110(3):301-8. PubMed ID: 15238462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.